Risk factors for massive hemorrhage during the treatment of cesarean scar pregnancy: a systematic review and meta-analysis

被引:20
|
作者
Zhang, Yuan [1 ,2 ,3 ]
Zhang, Zhongyun [4 ,5 ]
Liu, Xiaoyan [6 ]
Zhang, Lei [7 ]
Hong, Fanzhen [7 ]
Lu, Ming [1 ,2 ,3 ]
机构
[1] Shandong Univ, Cheeloo Coll Med, Sch Publ Hlth, Jinan, Peoples R China
[2] Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan, Peoples R China
[3] Shandong Univ, Clin Res Ctr, Jinan, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China
[5] Shandong Univ, Cheeloo Coll Med, Sch Med, Jinan, Peoples R China
[6] Shandong Univ, Dept Obstet, Qilu Hosp, Jinan, Peoples R China
[7] Shandong Univ, Dept Obstet, Hosp 2, Jinan, Peoples R China
基金
国家重点研发计划;
关键词
Cesarean scar pregnancy; Massive hemorrhage; Risk factors; Meta-analysis; HUMAN CHORIONIC-GONADOTROPIN; INTRAOPERATIVE HEMORRHAGE; MANAGEMENT;
D O I
10.1007/s00404-020-05877-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose Cesarean scar pregnancy (CSP) is one of the serious complications associated with cesarean delivery (CD). This meta-analysis aims to identify risk factors associated with massive hemorrhage during the CSP treatment. Methods Eight electronic databases were searched for case-control studies published before December 31th, 2018, which compared the possible factors causing massive bleeding during the CSP treatment. Quantitative synthesis was performed by RevMan 5.3. Sensitivity analysis and publication bias were performed by Stata 12.0. Results Total 20 case - control studies including 3101 CSP patients with previous CD met the inclusion criteria. Bleeding group had 573 patients and the control group had 2528 patients. The risk factors for massive bleeding during CSP treatment included multiple gravidities (MD = 0.15, 95% CI 0.03-0.28, P = 0.73), big maximum diameter of gestation sac (MD = 18.49 mm, 95%CI 15.34-21.65, P < 0.01), high gestational days (MD = 8.98 days, 95% CI 4.12-13.84, P < 0.01), high beta-HCG level (MD = 21.39 IU/ml, 95% CI 7.36-35.41, P = 0.03; MD = 3.02 U/ml, 95% CI 0.21-5.84, P < 0.01) and rich blood flow around the lesion (OR = 6.73, 95% CI 3.93-11.51, P = 0.59). While, thick myometrium (MD = - 4.94 mm, 95% CI - 6.12 to - 3.75, P < 0.01) may be protective factor. Conclusions Multiple gravidities, big gestation sac, large gestational days, high serum beta-HCG level, abundant blood supply to pregnancy sac and thin myometrium maybe the risk factors for massive bleeding during the CSP treatment.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [1] Risk factors for massive hemorrhage during the treatment of cesarean scar pregnancy: a systematic review and meta-analysis
    Yuan Zhang
    Zhongyun Zhang
    Xiaoyan Liu
    Lei Zhang
    Fanzhen Hong
    Ming Lu
    [J]. Archives of Gynecology and Obstetrics, 2021, 303 : 321 - 328
  • [2] A systematic review and meta-analysis of risk factors in the conservative treatment of cesarean scar pregnancy
    Wan, Xiaoli
    Liao, Yun
    Hu, Ting
    Xu, Hongmei
    Xia, Xiuying
    Peng, Yu
    Wang, Yan
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 10434 - 10443
  • [3] Evaluation of treatment of previous cesarean scar pregnancy with methotrexate: a systematic review and meta-analysis
    Salari, Nader
    Kazeminia, Mohsen
    Shohaimi, Shamarina
    Nankali, Anis Al-Dawlah
    Mohammadi, Masoud
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2020, 18 (01)
  • [4] Evaluation of treatment of previous cesarean scar pregnancy with methotrexate: a systematic review and meta-analysis
    Nader Salari
    Mohsen Kazeminia
    Shamarina Shohaimi
    Anis al-Dawlah Nankali
    Masoud Mohammadi
    [J]. Reproductive Biology and Endocrinology, 18
  • [5] Outcomes of reproduction following cesarean scar pregnancy treatment: A systematic review and meta-analysis
    Wu, Jiawen
    Ye, Jianbin
    OuYang, Zhenbo
    Wana, Zixian
    Zhang, Qiushi
    Zhong, Biting
    Wei, Shiyuan
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 262 : 80 - 92
  • [6] Treatment of cesarean scar pregnancy complicated with massive hemorrhage
    Shao, Huajiang
    Ma, Jianting
    Xu, Liping
    Yang, Xiuer
    Su, Xuefeng
    [J]. AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (08): : 520 - 524
  • [7] Analysis of risk factors for intraoperative hemorrhage of cesarean scar pregnancy
    Ma, Yan
    Shao, Minfang
    Shao, Xiaonan
    [J]. MEDICINE, 2017, 96 (25)
  • [8] Efficacy and safety of treatment modalities for cesarean scar pregnancy: a systematic review and network meta-analysis
    Fu, Peiying
    Sun, Haiying
    Zhang, Long
    Liu, Ronghua
    [J]. AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (08)
  • [9] Reproductive outcome after cesarean scar pregnancy: A systematic review and meta-analysis
    Morlando, Maddalena
    Buca, Danilo
    Timor-Tritsch, Ilan
    Cali, Giuseppe
    Palacios-Jaraquemada, Jose
    Monteagudo, Ana
    Khalil, Asma
    Cennamo, Carmen
    La Manna, Viviana
    Liberati, Marco
    D'Amico, Alice
    Nappi, Luigi
    Colacurci, Nicola
    D'Antonio, Francesco
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (10) : 1278 - 1289
  • [10] Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis
    Cali, G.
    Timor-Tritsch, I. E.
    Palacios-Jaraquemada, J.
    Monteaugudo, A.
    Buca, D.
    Forlani, F.
    Familiari, A.
    Scambia, G.
    Acharya, G.
    D'Antonio, F.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (02) : 169 - +